Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows DocTalk, Rare Disease Report, Heart Team, Overdrive, and Derm Discussions. Music Courtesy of BenSound
…
continue reading
1
New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD
30:42
30:42
Play later
Play later
Lists
Like
Liked
30:42
Corneal blindness has a significant public health impact, particularly in low- and middle-income countries where access to eye care is limited. It can contribute to a high burden of disability, affecting individuals' quality of life and economic productivity, while straining healthcare systems with the need for preventive measures, surgical treatme…
…
continue reading
1
Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD
7:06
7:06
Play later
Play later
Lists
Like
Liked
7:06
Proton pump inhibitors have long been the mainstay of treatment for gastroesophageal reflux disease (GERD), dating back to omeprazole (Prilosec)’s initial approval in 1989. However, the treatment landscape has undergone its first major changes in the past 30 years with the emergence of vonoprazan (Voquezna). A novel, first-in-class small molecule p…
…
continue reading
1
FDA First Half Recap: Dermatology in 2024
40:18
40:18
Play later
Play later
Lists
Like
Liked
40:18
Led by a flood of biologic therapies becoming available and progressing within the therapeutic pipeline, the field of dermatology finds itself in the midst of a watershed moment for many dermatologic conditions. To celebrate and recap the advancements occurring in the first half of 2024, the editorial team of HCPLive Dermatology sat down with James…
…
continue reading
1
New Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MD
21:19
21:19
Play later
Play later
Lists
Like
Liked
21:19
In the latest episode of New Insight with Veeral Sheth, MD, host Veeral Sheth, MD, director of clinical research at University Retina, speaks with Seemi Khan, chief medical officer at Alkeus Pharmaceuticals, on the company’s lead candidate being evaluated in clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondar…
…
continue reading
1
New Insight: A Look at the OcuLenz with Michael Freeman, CEO of Ocutrx
29:28
29:28
Play later
Play later
Lists
Like
Liked
29:28
Since the mid-20th century ushered in the ‘Information Age’, a desire for innovation has driven the pursuit of technological advancements. Many may immediately consider the transformations personal computers and smartphones have had on modern society, but these advancements have transformed the fields of medicine time and time again. In the latest …
…
continue reading
1
Andrew F. Alexis, MD, MPH: Discussing Controversies in Acne, Rosacea
8:41
8:41
Play later
Play later
Lists
Like
Liked
8:41
Episode Highlights: 0:16 Intro 0:28 Overview of presentation 0:38 Acne and post-inflammatory hyperpigmentation 01:35 Approaches to take 03:21 Rosacea, use of dermoscopy and symptomatology assessment 04:59 Necessity of inclusivity in clinical trials, other knowledge gaps 06:05 Images used in education The American Academy of Dermatology (AAD) Annual…
…
continue reading
1
New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk
29:44
29:44
Play later
Play later
Lists
Like
Liked
29:44
In the medical community, a revolving cast of players plays a pivotal role in advancing scientific discovery and enhancing patient outcomes. During the research stage, a collaborative team effort, from the clinical trial sponsors to research sites and patient populations, is essential to ensure smooth progress and sustain momentum toward the finish…
…
continue reading
1
New Insight: Reengaging the Retina Community in 2024 w/ David Eichenbaum, MD and Roger Goldberg, MD
40:00
40:00
Play later
Play later
Lists
Like
Liked
40:00
A special double-episode of New Insight with Veeral Sheth, MD features a well-rounded conversation on all things ophthalmology with returning guest David Eichenbaum, MD, the director of research for Retina Vitreous Associates of Florida, as well as first-time guest Roger Goldberg, MD, a vitreoretinal surgeon at Bay Area Retina Associates. The trio …
…
continue reading
1
New Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MD
21:30
21:30
Play later
Play later
Lists
Like
Liked
21:30
In every episode of New Insight, Veeral Sheth, MD, Director of Clinical Trials at University Retina in Chicago, takes an in-depth look at the biggest news in ophthalmology and the behind the scenes work involved in eye care, with a rotation of guest experts involved in ophthalmic research, development, and clinical care. The latest episode of New I…
…
continue reading
1
New Insight: Phase 2 BEHOLD Study and UBX1325 for DME, Live at AAO 2023
7:24
7:24
Play later
Play later
Lists
Like
Liked
7:24
On the floor at AAO 2023, host Veeral Sheth, MD, and producer Connor Iapoce discuss UBX1325 for patients with diabetic macular edema, based on the 48-week results from the phase 2 BEHOLD study. Episode Highlights: 0:30 Introduction 0:48 Background into UBX1325 and BEHOLD 2:49 BEHOLD 48-week results 6:05 Next steps 6:56 Conclusion Please direct any …
…
continue reading
1
Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD
15:51
15:51
Play later
Play later
Lists
Like
Liked
15:51
Episode Highlights 0:12 Intro 1:24 Challenges in autoimmune hepatitis 3:30 Patient demographics 4:25 Diagnostic challenges 6:35 What is overlap syndrome? 8:04 Mysteries behind immune dysregulation 9:05 Promising drugs in investigation 10:51 The BAFF receptor target 11:41 Infliximab & rituximab 12:38 An autoimmune hepatitis wishlist 15:29 Outro Auto…
…
continue reading
1
New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD
33:33
33:33
Play later
Play later
Lists
Like
Liked
33:33
Host Veeral Sheth, MD is joined by Megan Baldwin, PhD, CEO and Managing Director of Opthea Limited, to discuss OPT-302 or sozinibercept, the company's novel anti-VEGF-C / VEGF-D treatment for wet AMD and other retinal diseases. Episode Highlights: 0:06 Introduction 0:37 Background of Dr. Baldwin 9:56 Promising data on OPT-302/sozinibercept 16:39 Ma…
…
continue reading
Warren Jones, PhD, scientific founder of EarliTec Diagnostics and autism expert, discusses his team's development of an eye-tracking device recently authorized by the FDA and proven in clinical trials to predict autism consistent with expert diagnoses.By HCPLive.com
…
continue reading
1
COVID-19 Cases Are Climbing, with Donald Alcendor, PhD
34:56
34:56
Play later
Play later
Lists
Like
Liked
34:56
After a historically low-transmission summer, new cases, hospitalizations and deaths due to COVID-19 have increased by approximately 18% in the US over the last week, according to CDC data. In a new DocTalk interview, Donald J. Alcendor, PhD, associate professor, department of pathology microbiology and immunology, division of infectious diseases, …
…
continue reading
In this episode, host Veeral Sheth, MD, and producer Connor Iapoce discuss 5 important presentations from ASRS 2023. The discussion centers around new data on geographic atrophy therapies, novel agents for DME, and the feasibility of home OCT. Please direct any podcast-related inquiries to ciapoce@mjhlifesciences.com.…
…
continue reading
1
6: New Insight: Mentorship and the Next Generation with David Eichenbaum, MD
37:12
37:12
Play later
Play later
Lists
Like
Liked
37:12
The newest episode of New Insight with Veeral Sheth, MD features a conversation with David Eichenbaum, MD, the director of research for Retina Vitreous Associates of Florida. A seasoned clinical trial investigator and a friendly face at major medical meetings, Eichenbaum provides insights into his goals behind mentorship and inspiring others, shari…
…
continue reading
1
5: New Insight: The Journey to a Drug Approval with Cedric Francois, MD, PhD
34:13
34:13
Play later
Play later
Lists
Like
Liked
34:13
In the latest episode of New Insight, Veeral Sheth, MD sat down with Cedric Francois, MD, PhD, co-founder and chief executive officer/president of Apellis Pharmaceuticals. The two experts discussed the company's landmark therapy, pegcetacoplan (SYFOVRE™), for geographic atrophy and the decades-long journey toward FDA approval. Sheth also asked abou…
…
continue reading
1
4: New Insight: Making Waves in the Biotech Space with Jay Duker, MD
35:04
35:04
Play later
Play later
Lists
Like
Liked
35:04
In this episode, Veeral Sheth, MD, sits down with Jay Duker, MD, the president and chief operating officer of Eyepoint Pharmaceuticals, for a discussion on his storied career in ophthalmology, the importance of fostering a relationship between clinicians and industry, and the current biotech Dr. Duker and team are working on at Eyepoint. Please dir…
…
continue reading
1
3: New Insight: A Changing Landscape of Retinal Therapeutics with Charles Wykoff, MD, PhD
29:41
29:41
Play later
Play later
Lists
Like
Liked
29:41
In this episode, Charles Wykoff, MD, PhD joins Dr. Sheth to provide insight into the recent landmark approval of pegcetacoplan injection (SYFOVRE™) for geographic atrophy, how clinical practice has changed as a result, and both the early struggles with and optimism for an ever-changing treatment landscape. Please direct any podcast-related inquirie…
…
continue reading
1
2: New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD
33:22
33:22
Play later
Play later
Lists
Like
Liked
33:22
As part of our ARVO 2023 coverage, Dr. Sheth sat down with Pravin Dugel, MD, President of Iveric Bio. Together, the experts discussed the lead molecule for the company, avacincaptad pegol for geographic atrophy, and touched on the data being presented at the conference, as well as a look back at Dugel's career and his transition into industry.…
…
continue reading
1
1: New Insight: The State of Retina Today, and Where We're Heading with Arshad Khanani, MD
23:09
23:09
Play later
Play later
Lists
Like
Liked
23:09
The inaugural episode of New Insight with Veeral Sheth, MD, our premier ophthalmology-focused podcast, features a conversation with Arshad Khanai, MD, the Director of Clinical Research at Sierra Eye Associates in Reno, Nevada. Together, our experts discuss their background and education in retina, and how they started working on clinical trials. Th…
…
continue reading
1
A First Look at New Insight with Veeral Sheth, MD
6:24
6:24
Play later
Play later
Lists
Like
Liked
6:24
The latest offering from HCPLive Podcasts is New InSight with Veeral Sheth, MD, an in-depth series examining the biggest news in ophthalmology. The podcast will feature conversations on research news and new therapies, landmark findings from major medical meetings, and the day-to-day life of an ophthalmologist in the 21st century. A range of guests…
…
continue reading
1
Kirsten Johansen, MD: Improving the Quality of Life for CKD Patients With Anemia
14:48
14:48
Play later
Play later
Lists
Like
Liked
14:48
By HCPLive.com
…
continue reading
1
Reaction to the Historic Approval of RBX2660
32:40
32:40
Play later
Play later
Lists
Like
Liked
32:40
By HCPLive.com
…
continue reading
1
Advances in Pediatric Eczema Highlight 2022
21:35
21:35
Play later
Play later
Lists
Like
Liked
21:35
Lawrence Eichenfield, MD, reviews major drug approvals and advancement of screening and prevention strategies for the youngest patients with atopic dermatitis.By HCPLive.com
…
continue reading
1
What Ruxolitinib Cream Meant For Dermatology in 2022
13:18
13:18
Play later
Play later
Lists
Like
Liked
13:18
As 2022 concludes, a dermatologist reflects on the first drug approved for vitiligo.By HCPLive.com
…
continue reading
1
A Geographic Atrophy Treatment Breakthrough with David R. Lally, MD
18:47
18:47
Play later
Play later
Lists
Like
Liked
18:47
Dr. Lally of New England Retina Consultants joins to discuss avacincaptad pegol, a promising injection treatment for GA, and its supporting data from the GATHER trial program. Will the complement C5 inhibitor drug receive FDA approval in 2023? Lally discusses this and more on the latest DocTalk.By HCPLive.com
…
continue reading
1
ACR 22 Convergence Preview, with Dr. McMahan
13:04
13:04
Play later
Play later
Lists
Like
Liked
13:04
Ahead of the American College of Rheumatology 2022 Convergence meeting on Nov. 10-14, our editorial team sat down with planning committee member Zsuzsanna McMahan, MD, MHS, of Johns Hopkins University School of Medicine, to take a deep dive into the upcoming meeting.By HCPLive.com
…
continue reading
1
Rare Disease Report: The FDA Decision for Pompe Disease Therapy
13:25
13:25
Play later
Play later
Lists
Like
Liked
13:25
The FDA is expected to announce the final decision for the dual therapy AT-GAA, which uses miglustat in combination with cipaglucosidase alfa for treating Pompe disease, an inherited and often times fatal disorder. Expert Barry Byrne discusses the characteristics of the condition and what this FDA decision will mean for treatment.…
…
continue reading
1
Arshad Khanani, MD: A Breakthrough in Geographic Atrophy Treatment
12:30
12:30
Play later
Play later
Lists
Like
Liked
12:30
One of the most notable topics discussed at the 2022 American Academy of Ophthalmology Meeting in Chicago was new advancements in geographic atrophy (GA) treatment. A form of advanced age-related macular degeneration (AMD), there are no currently available treatments for the debilitating disease. In this episode of DocTalk, we spoke with Arshad Kha…
…
continue reading
1
Rare Disease Report: Newborn Screening Awareness & Novel Diagnostic Tool
20:46
20:46
Play later
Play later
Lists
Like
Liked
20:46
In the wake of Newborn Screening Awareness Month, this episode dives into a novel diagnostic precision medicine guidance tool called BeginNGS. Catherine Nester, RN, and Dr. Stephen Kingsmore, discuss the pivotal role of newborn screening in diagnosing rare diseases. As representatives from collaborating partners Inozyme Pharma and Rady Children's I…
…
continue reading
1
Heart Team: Making Ground on Women's Cardiovascular Health with Martha Gulati, MD
23:31
23:31
Play later
Play later
Lists
Like
Liked
23:31
Martha Gulati, MD, Director of Preventive Cardiology, Associate Director of the Barbara Streisand Women’s Heart Center, Associate Director of Preventive and Cardiac Rehabilitation at Cedars-Sinai Medical Center, joins Heart Team to discuss current challenges in women’s cardiovascular disease research and clinical advancement. Gulati also provides g…
…
continue reading
1
Marla Dubinsky, MD: The Future of IIL-23 Treatments for IBD
24:13
24:13
Play later
Play later
Lists
Like
Liked
24:13
By HCPLive.com
…
continue reading
1
Heart Team: Cardiology & Nephrology Collaborations with Dr. Matthew Weir
31:14
31:14
Play later
Play later
Lists
Like
Liked
31:14
In the first episode from this new cardiovascular medicine series, hosts Dr. Jorge Plutzky and Dr. Michael Farkouh speak with University of Maryland's Dr. Matthew Weir about the growing involvement of renal care in modern heart disease patients.By HCPLive.com
…
continue reading
1
Rare Disease Report: CDKL5 Deficiency Disorder Expert Interview
19:05
19:05
Play later
Play later
Lists
Like
Liked
19:05
The second episode of the 2-part Rare Disease Report shifts to a clinical perspective with the expertise of Dr. Pestana, a pediatric epileptologist at the Epilepsy Center, Cleveland Clinic Neurological Institute who treats patients with CDKL5 deficiency disorder (CDD).By HCPLive.com
…
continue reading
1
Rare Disease Report: CDKL5 Deficiency Disorder
23:51
23:51
Play later
Play later
Lists
Like
Liked
23:51
In the first episode of a 2-part Rare Disease Report, Whitney Mitchell, mother and caregiver to her 6 year old daughter Havilah, shared her experience leading up to, and now living with, Havilah’s CDKL5 deficiency disorder (CDD) diagnosis.By HCPLive.com
…
continue reading
1
John J. Miller, MD: A New Era For Psychiatric Medications
17:29
17:29
Play later
Play later
Lists
Like
Liked
17:29
By HCPLive.com
…
continue reading
1
Nonprofit Research on Gene Therapy for Rare Ocular Diseases
13:47
13:47
Play later
Play later
Lists
Like
Liked
13:47
By HCPLive.com
…
continue reading
1
Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030
20:02
20:02
Play later
Play later
Lists
Like
Liked
20:02
By HCPLive.com
…
continue reading
1
The Biggest Discussions in Retina from the 2022 ASRS Annual Meeting
13:46
13:46
Play later
Play later
Lists
Like
Liked
13:46
This past week, the American Society of Retina Specialists (ASRS) held its 40th Annual Meeting in New York City to discuss landmark data and the newest advancements in retina care. The HCPLive team was on-site at the Javits Center in Manhattan conducting interviews with expert retina specialists on topics including drugs for neovascular age-related…
…
continue reading
1
FDA Approves Ruxolitinib: New Horizons in Vitiligo Care
8:13
8:13
Play later
Play later
Lists
Like
Liked
8:13
On Monday, the US Food and Drug Administration (FDA) approved ruxolitinib cream 1.5% for the treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older, making it both the first FDA-approved therapy for repigmentation and the only topical formulation of a JAK inhibitor approved in the United States. The groundbreaking ap…
…
continue reading
1
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
15:57
15:57
Play later
Play later
Lists
Like
Liked
15:57
Last week, the US Food and Drug Administration (FDA) approved the co-treatment of pegloticase (Krystexxa) injection plus methotrexate (MTX) for uncontrolled gout, a decision bolstered by data from phase 4 of the MIRROR study. In that study, 71% of patients who were treated with this combination therapy achieved a complete response over the course o…
…
continue reading
1
What Ustekinumab Provides in Long-Term IBD Care
14:15
14:15
Play later
Play later
Lists
Like
Liked
14:15
Despite a bevy of biologics available for people struggling with Crohn’s disease and ulcerative colitis (UC), not all patients are able to respond to or tolerate a vast majority of approved therapies. Fortunately, new data presented at Digestive Disease Week (DDW) 2022 suggests that ustekinumab (STELARA) could function as an alternative option to b…
…
continue reading
1
Exploring New Horizons in Ophthalmology Care with Gene Therapy
9:13
9:13
Play later
Play later
Lists
Like
Liked
9:13
If you’ve been keeping an eye on recent developments in ophthalmic care, then you’ll know that several new therapeutic agents that had been approved by the US Food and Drug Administration (FDA) in recent months, including ranibizumab delivered via Port Delivery System (PDS) and faricimab, the latter of which became the first-of-its-kind intravitrea…
…
continue reading
1
How the Newest Dupilumab Approval Solves an "Unmet Need" in Children with AD
17:14
17:14
Play later
Play later
Lists
Like
Liked
17:14
Earlier this month, dupilumab became the first and only biologic medicine approved by the US Food and Drug Administration for the treatment of atopic dermatitis in patients of all ages, from infancy through adulthood. The approval of dupilumab as an add-on maintenance therapy for children 6 months to 5 years with moderate to severe atopic dermatiti…
…
continue reading
1
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata
22:38
22:38
Play later
Play later
Lists
Like
Liked
22:38
On June 13, the US Food and Drug Administration (FDA) approved oral baricitinib (Olumiant) tablets for the treatment of severe alopecia areata in adults, which marked the first approval of a systemic treatment for the disorder. The approval has excited patients and providers alike who struggled for decades to treat severe cases of this autoimmune d…
…
continue reading
1
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata
22:09
22:09
Play later
Play later
Lists
Like
Liked
22:09
On June 13, the US Food and Drug Administration (FDA) approved oral baricitinib (Olumiant) tablets for the treatment of severe alopecia areata in adults, which marked the first approval of a systemic treatment for the disorder. The approval has excited patients and providers alike who struggled for decades to treat severe cases of this autoimmune d…
…
continue reading
1
Sleeping Through Infectious Disease and the COVID-19 Vaccine
21:56
21:56
Play later
Play later
Lists
Like
Liked
21:56
After presenting at the SLEEP 2022 annual meeting, Dr. Aric Prather explains the findings of his previous research demonstrated lack of sleep (6 hours or less) was associated with a 4 times higher risk of becoming sick after exposure to rhinovirus in an interview with HCPLive. Currently, Prather and his team at UCSF are working with a large naive p…
…
continue reading
1
Multi-System Approaches to Treating Pediatric Morphea
9:08
9:08
Play later
Play later
Lists
Like
Liked
9:08
In recognition of National Scleroderma Awareness Month, HCPLive spoke with several prominent dermatologists today who addressed some of the concerns and advancements related to the rare, multi-system disease. Scleroderma is often referred to as “morphea” by dermatologists, and the condition typically presents with the tightening and hardening of th…
…
continue reading
1
Roberto Simons-Linares, MD: The Importance of Bariatric Surgery
8:50
8:50
Play later
Play later
Lists
Like
Liked
8:50
By HCPLive.com
…
continue reading